Abstract
Peru has the highest incidence of human cystic echinococcosis (CE) in South America and most cases are reported in the Central and Southern Peruvian Andes, including the Cusco region. We reviewed medical records of patients with CE admitted between 2010-2019 to a level 2 Hospital in Sicuani, to collect data on the surgical management and disease recurrence in the Canchis province of Cusco. Records of 115 patients were analyzed in detail. The median age was 25 years (IQR, 16-46) and 60% were female. Most patients (68.7%) presented with a single liver cyst. The Gharbi classification was used in 75/107 (70.1%) patients with an ultrasound and 91/142 cysts (64.8%). Thirty one (34.1%) were classified as Gharbi I, 33 (36.3%) Gharbi II, 21 (23.1%) Gharbi III, and 6 (6.6%) Gharbi IV. Pre-surgical complications were reported in 41.7%. One hundred two patients underwent surgery. In 46.1%, one cyst spillage prevention measure was documented, 5.9% had two, and one had the three recommended measures. Post-surgical cyst recurrence was reported in 16.5% at a median 32.3 months (IQR, 3.9-46.6) and readmissions in 12.7%. In the multivariable analysis, having ≥3 cysts (OR 9.5, 95% CI 1.3-85.5), having two pre-surgical complications (OR 12.6, 95% CI 1.8-125.6), and receiving pre-surgical albendazole (OR 5.2, 95% CI 1.3-23.9) were associated with cyst recurrence. Advanced and complicated CE disease and post-surgical recurrence were common in Sicuani. Standardization of ultrasound staging-guided clinical management along with surgical spillage prevention measures could effectively decrease the disease burden linked to clinical care, improving outcomes and decreasing costs.
Introduction
Cystic echinococcosis (CE) is a parasitic zoonosis caused by the metacestode stage of the dog tapeworm Echinococcus granulosus (1). E. granulosus has a global distribution, being endemic in South America, North and East Africa, Central Asia and China (2). Peru has the highest incidence of CE in South America, accounting for 84.8% of all reported cases in year 2018 (3). The district of Sicuani in the Cusco region is a highly endemic area in the Southern Peruvian Andes. Up to 45% of CE cases referred to tertiary care hospitals in Cusco are from Sicuani (4). A population survey in four communities also found the highest prevalence in Sicuani (5). The economic and urban expansion of the Sicuani city have created areas where informal livestock slaughter activities, stray dogs, and humans interact closely. Prompt diagnosis and appropriate treatment of cases in Sicuani are crucial to address the burden of CE in the healthcare system.
The WHO-Informal Working Group on Echinococcosis (WHO-IWGE) ultrasound staging system is used to diagnose and guide the clinical management of liver CE (6). However, many low- and middle-income countries (LMIC) have not implemented the proposed WHO ultrasound staging exposing patients to unnecessary procedures (7). CE is associated with high post-surgical recurrence risk, with rates that range between 4.7% and 16.4% (8-11). Clinical characteristics such as the cyst size, number of cysts, and presence of complications have been associated with disease severity and recurrence (10, 12, 13). Treatment precautions to avoid cyst rupture and spillage may decrease the risk of recurrence related to surgical care.
The expert consensus on diagnosis and treatment of CE recommends the use of hypertonic saline-soaked drapes for surgical field protection, injection of a scolicidal agent into the cyst, and prescription of pre-surgical albendazole (ABZ) to prevent intraabdominal protoscolex spillage during surgery (6). Increasing evidence shows that appropriate standardization of surgical procedures may be associated with lower risk of recurrence (14-16). Similarly, the “watch-and-wait” approach for inactive cysts should be the standard of care to spare asymptomatic patients from unnecessary treatment (17, 18).
We conducted a review of medical records of patients hospitalized in the Alfredo Callo Rodriguez Hospital in Sicuani during a 10-year period to describe the CE management in Sicuani, determine the post-surgical recurrence rate, and the risk factors for recurrence.
Methods
Study design and setting
This is a review of medical records from patients hospitalized at the Alfredo Callo Rodriguez Hospital in Sicuani. This hospital is a level 2 public health center that provides specialty medical care to patients from the Canchis and Canas provinces of Cusco (19). We collected data from all patients admitted to the hospital for CE between January 1, 2010 and December 31, 2019. The pre-COVID-19 period was selected to avoid collecting information that could reflects gaps in care or practice of CE treatment in Sicuani because of the public health emergency. This timeframe also coincides with the renovation and expansion of surgical services in the hospital in 2010.
The city of Sicuani is the capital of the Canchis province in the Cusco region at an elevation of 3,548 meters above sea level. The Sicuani district has an urban population of 47,386 and a rural population of 10,441 habitants (20). Sicuani is a commerce center for farmers of the surrounding areas and is the second largest city in the Cusco region.
Study procedures
Medical record numbers of patients with CE were identified using ICD-10 codes (B67.0-B67.9) assigned as the discharge diagnosis through the Hospital’s Statistics Department. Surgical logbooks were handsearched to ensure all surgical CE cases were retrieved. Demographic and clinical data were collected via ODK software (© 2022 Get ODK Inc., California, USA) using an electronic Case Report Form, which was piloted at the start of data collection to ensure data accuracy.
Definitions
The three evaluated spillage-prevention measures included the use of drapes soaked on hypertonic saline for surgical field protection, injection of hypertonic saline into the cyst prior to evacuation of contents, and the prescription of pre-surgical ABZ (6). Post-surgical recurrence was defined as the development of a new cyst at or near the site of the previously removed metacestode and/or within a cavity (e.g., peritoneum, pleura) where cyst(s) were operated on. The time-to-recurrence was estimated as the time from the surgery date until the date of recurrence diagnosis. In one case the date of recurrence was recorded as “2024” and it was assigned the first day of this year as the date. New cyst was defined as a newly diagnosed cyst in a location different from other operated cysts. Readmission was defined as return to inpatient care related to CE after discharge. Readmission rate was calculated by dividing the number patients with at least one readmission by the total number of hospitalization discharges.
Cumulative incidence calculation
The annual cumulative incidence of new hospital admissions was calculated dividing the number of new CE hospitalizations per year by the total population at risk each year. The population at risk was defined as the total population of the Canas and Canchis provinces per year. Population data for years 2015 to 2019 was extracted from a repository database of the Peruvian Ministry of Health and data for years 2009 to 2014 was extracted from CPI database (21, 22).
Statistical analysis
Data analysis and visualization were performed using the R software, version 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria). Means with standard deviation (SD), medians with interquartile range (IQR), and frequencies were used to assess the distributions of demographic, epidemiological, and clinical characteristics of patients. The association between variables and the outcome ‘post-surgical recurrence’ was assessed using non-parametric tests such as Chi-Square and Fisher’s exact test. A multivariable logistic regression analysis was performed to determine independent associations with the outcome variable. We assessed a pre-defined model with variables of clinical or epidemiological relevance in unadjusted logistic regression analyses for each variable.
These variables included age, sex, duration of symptoms, cyst diameter, number of cysts, pre-surgical complications, affected liver lobe or segment, spillage prevention measures, post-surgical ABZ, and post-surgical complications. Variables with significant associations in the unadjusted models were considered in the multivariable analysis. The multivariable model was adjusted for age and sex. A P value of <0.05 was considered statistically significant. Confidence intervals were calculated at the 95% level.
Ethical Statement
This study was reviewed and approved by the Ethics Committee of Northern and Central Switzerland (Ethikkommission Nordwest-und Zentralschweiz, EKNZ) and the Institutional Ethics Committee (Comite Institucional de Etica en Investigacion) of the Universidad Peruana Cayetano Heredia in Lima, Peru.
Results
Demographic and clinical characteristics
One hundred and twenty-five medical record numbers were identified. Six were duplicated, 2 were mislabeled as CE, and 2 had missing charts. In total, 115 unique medical records from patients with CE and clinical information were included in the study (Table 1). The median age was 25 years (IQR, 16-46) and 60% were female. Most patients (103, 89.6%) were residents of the Canchis province and 73.9% lived in the Sicuani district. Fifty-six patients (48.7%) were referred from primary healthcare centers, and 57.1% of these were referred from the Pampaphalla health center.
One hundred eighty-five echinococcal cysts were diagnosed in the 115 patients, 169 were diagnosed upon presentation to the hospital and 16 during readmissions. These involved the liver, lungs, stomach, spleen, duodenum, gallbladder, diaphragm, adnexa, bladder, and colon. Most (142, 84%) were located in the liver, 16 within the abdominal cavity, and 11 in the lungs. Four patients had disseminated liver and intraabdominal cysts. The maximum number of lung cysts per patient was 2. The median largest diameter for liver cyst was 12.8 cm (IQR, 9.2-15.0) and for lung cysts was 8.5 cm (IQR, 4.5-12.6). Seventy-seven (67%) patients carried a liver cyst of ≥10 cm diameter.
Most patients (98, 85.2%) presented with only liver cysts, 7 (6.1%) with both liver and intraabdominal cysts, 5 (4.3%) with liver and lung cysts, and 5 (4.3%) with only lung cysts (Table 2). Most patients presented with a single liver cyst (79, 68.7%). Forty-eight (41.7%) cases presented with complicated cysts before surgery, 31 (27%) had one pre-surgical complication, 8 (7%) had two, and 9 (7.8%) had three or more. The most common cyst complications before surgery were infection of the cyst content (17, 14.9%), cysto-biliary fistulas (9, 7.8%), liver abscess (9, 7.8%), cyst rupture (8, 7.0%), and peritonitis (5, 4.3%) (Table 3).
Ultrasound diagnosis
One hundred seven patients (93%) had a diagnostic ultrasound. In 75 (70.1%), a liver ultrasound was performed and used for staging according to the Gharbi classification (6) and in 20 (18.7%) a liver ultrasound was performed but no staging was reported. Twelve patients had lung cysts, disseminated disease, complicated cysts, or unclear or missing ultrasound reports precluding the use of a cyst diagnostic and management classification. In total, 91 (64.8%) of the 142 liver cysts were staged using the Gharbi classification. Thirty-one (34.1%) were Gharbi I, 33 (36.3%) Gharbi II, 21 (23.1%) Gharbi III, and 6 (6.6%) Gharbi IV. Seven (6.1%) patients were diagnosed with inactive cysts, including one who had a Gharbi IV cyst diagnosed intraoperatively. In one of these patients, the cyst was described in the surgical report as containing multiple daughter cysts (Gharbi III).
Treatment, protoscolex-spillage prevention measures, and post-surgical complications
Only patients with liver and intraabdominal cysts underwent surgery in Sicuani (102, 88.7%). Ninety five of the 102 patients (93.1%) underwent conventional surgery, 6 (5.9%) laparoscopic surgery, and one laparoscopic surgery converted to conventional laparotomy. The most common surgical techniques were cystectomy plus drainage (74, 72.5%) and pericystectomy plus drainage (9, 8.8%) (Table 4). In one case a Gharbi IV cyst was found and not excised and two patients with inactive cysts (2%) underwent excision. In one case the liver cyst was not found during the surgery. None of the patients had a percutaneous procedure performed. In 18 (17.6%) patients, the operative report did not describe the anatomical location of the liver cyst. Seventy (68.6%) patients had right liver lobe cysts, 26 (25.5%) left liver lobe cysts, and 12 (11.8%) had cysts in both liver lobes. In 46 (45.1%) patients the liver segment VIII was involved, in 32 (31.4%) the segment VII, in 24 (23.5%) the VI, in 17 (16.7%) the IV, in 12 (11.8%) the V, in 10 (9.8%) the II, in 8 (7.8%) the III, and in one patient the segment I.
Forty-seven (46.1%) patients had at least one surgical spillage prevention measure documented, 6 (5.9%) had two, and only one had the three recommended spillage prevention measures. Pre-surgical ABZ was used in 33 (32.4%) cases, injection of hypertonic saline into the cyst before evacuation of contents was used in 16 (15.7%) cases, and drapes soaked with hypertonic saline were used for surgical field protection in 6 (5.9%) cases. Peri-surgical ABZ within 6 hours of surgery was not used in any of the cases (16).
ABZ was the only antiparasitic prescribed. In 57 (55.9%) patients, ABZ was prescribed after surgery, in 27 (26.5%) before and after surgery, in 7 (6.9%) no ABZ was prescribed, in 6 (5.9%) ABZ was prescribed only before surgery, and in 5 cases the timing of the prescription was unknown. The median post-surgical duration of ABZ treatment prescribed was 30 days (IQR, 22-34) and the median pre-surgical duration of ABZ treatment prescribed was 2 days (IQR, 1-4).
Post-surgical complications occurred in 22 (21.6%) patients. The most common were the development of residual fluid collections (14, 13.7%), post-surgical abscess (3, 2.9%), and biliary leakage (3, 2.9%) (Table 3). The three patients with post-surgical liver abscess were readmitted to the hospital.
Post-surgical recurrence, readmission, and cumulative incidence
One patient required a second surgical intervention within the same hospitalization for post-surgical biliary leak, and one required intensive care due to post-surgical hemodynamic instability. Eleven (9.6%) patients were referred to a higher level of care, 9 for treatment of pulmonary CE, 1 for post-surgical shock, and 1 for potential need of post-surgical intensive care. Of these, 10 patients went to the Hospital Regional del Cusco and 1 patient to the Hospital Antonio Lorena in Cusco. Post-surgical recurrence was documented in 16/97 (16.5%) patients. The median time to recurrence after surgery was estimated at 32.3 months (IQR, 3.9-46.6). The multivariable logistic regression analysis showed that having ≥3 cysts compared to 1 cyst (50% vs 15.1%, OR=9.54, 95% CI 1.33-85.47), having two pre-surgical complications compared to having none (57.1% vs 16.9%, OR=12.62, 95% CI 1.8-125.64), and receiving a prescription for pre-surgical ABZ compared to not receiving it (27.3% vs 10.9%, OR=5.16, 95% CI 1.33-23.93) were associated with post-surgical recurrence (Figure 1).
Forest plot exhibiting the multivariable logistic regression analysis for post-surgical recurrence. The left column shows the explanatory variables. Odds ratios and confidence intervals in black represent unadjusted logistic regression models for each independent variable. Odds ratios and confidence intervals in blue represent the multivariable analysis.
ABZ, albendazole, CI, confidence interval, OR, odds ratio.
Fourteen (14/110, 12.7%) patients were readmitted to the Hospital de Sicuani at least once, 6 did for cyst recurrence, 2 for treatment complications, 2 for complications of a previous cyst plus cyst recurrence, 3 for elective two-stage treatment, and one for a new cyst. One patient had 2 readmissions. Twelve out of the 14 patients with readmissions had active echinococcal cysts. The median age was 40 years (IQR, 26.5-62), 7 (58.3%) were female, and 5 (41.7%) were referred from the Pampaphalla health center. Single liver cyst was the presentation in 9/12 (75%) of patients with readmissions. Readmissions contributed with 16 additional cysts to the overall count for the 10-year study period. The annual cumulative incidence of new hospital admissions for CE at the Alfredo Callo Rodriguez Hospital of Sicuani are reported in Table 5.
Discussion
Our study describes the clinical characteristics and management of CE at a secondary care level hospital located in an endemic area in the Southern Peruvian Andes. We found that most CE patients requiring hospital admission in Sicuani were part of the economically active population and one-third were younger than 18 years. Advanced echinococcal disease was common, with nearly 70% of patients having liver cysts ≥10 cm in diameter and 42% presenting with pre-surgical complications. Despite the use of ultrasound in the evaluation of CE in 90% of the cases, the WHO-IWGE system for diagnosis and management of liver CE was not used in any of the patients. Instead, the Gharbi classification was used on a limited number of cysts. Spillage prevention measures were documented in less than half of the surgical procedures performed. One in six patients had recurrence of CE after surgery and one in eight patients was readmitted to the hospital at least once. Our data suggest that educational interventions could improve the medical and surgical management of CE in Hospital Sicuani and decrease the morbidity associated with disease recurrence and surgical procedures.
The Alfredo Callo Rodriguez Hospital of Sicuani serves as a referral center to the Canas and Canchis provinces. These provinces have a large young age populations being prominently affected by CE. The latent period of CE, between infection and clinical presentation, typically lasts many years suggesting that active transmission occurs in Sicuani and that it occurs early in life. A large case series of hospitalized patients in the Extremadura and Castilla-Leon regions of Spain showed a distribution skewed towards the older age groups with only 2% cases presenting in patients younger than 19 years (23, 24). The authors attributed this age distribution in part to the successful interruption of CE transmission by control programs. A similar scenario was described in Chile, where most reported cases between 2018-2022 were diagnosed among patients 45 to 74 years (25). Efforts to control CE transmission in the Canas and Canchis provinces were limited to the treatment of dogs in rural areas and sporadic screening of children. A concerted effort with a One Health approach is needed to formulate control strategies in the area.
Most of the patients in our study had liver cysts and 41.7% presented with complications. This proportion of complications is comparable with a study in Salamanca, Spain (40.3%) but higher than other case series (4%) (26, 27). Collado-Aliaga and colleagues (26) found in a tertiary care hospital a bigger proportion of mechanical complications (25% vs 20%), including biliary fistulas (13.4% vs 7.8%) and mass effect (5.5% vs 4.4%). We observed a larger proportion of infectious complications (25.2% vs 17.8%), cyst rupture (8.7% vs 2.9%), and cysts >10 cm in diameter (68.7% vs 45% >7 cm). These differences could be due to selection bias from hospital level of care or complexity of the clinical care (secondary vs tertiary care), and differences in healthcare access.
Having two pre-surgical complications was associated with increased odds of post-surgical recurrence compared to not having complications. Single complications including cyst rupture and fistulas did not have an association with recurrence. Other studies were also unable to demonstrate associations of infectious, mechanical or allergic complications and recurrence (9, 26). In one of these studies, 64% patients were asymptomatic at the moment of diagnosis, which could indicate that the risk of recurrence depends on more than one clinical variable but on surgical technique performance and post-surgical care (9). Larger cyst diameter has been proposed as a marker of disease severity and a risk factor for recurrence (12). We did not find an association between cyst diameter and pre-surgical complications, recurrence, or readmission. Although other studies reported cysts with smaller sizes (median 6.6 cm and 10 cm vs 13 cm in our cohort), these could not demonstrate an associations with complications or recurrence either (11, 13, 26). We did observe an independent association between increasing number of cysts and the risk of post-surgical recurrence in our patients. Number of cysts has been previously identified as a risk factor for complications and recurrence. For example, Pacifico and colleagues detected four-times increased risk for recurrence among those with ≥3 cysts, and another study also found having ≥3 cysts was an independent risk factor for recurrence (10, 13). This could be the result of large parasitic burden secondary to repeated cycles of infection or subclinical cyst rupture and seeding long prior to hospital admission.
Documentation of adequate ultrasound staging was observed in 91 out 142 diagnosed liver cysts. Ultrasound diagnosis is not yet fully implemented in LMIC (7). In none of the cases reviewed in this study the WHO-IWGE staging system was used. The WHO-IWGE classification serves as a guide for the clinical management to either medical, percutaneous, surgical or ‘watch and wait’ approach (6). Thirty-six (35.3%) patients who underwent surgery in our study presented without complications and had Gharbi I or II liver cysts, being in 5 cases between 5-10 cm in diameter and in 30 cases ≥10 cm. Some of these patients could have been candidates for percutaneous treatment (28); however, this treatment option is still not widely available in Peru. Patients with Gharbi III cysts in our study had a greater proportion of post-surgical recurrence (29.4%) compared to the other stages (10.7% of Gharbi I, 7.7% of Gharbi II, and 0% of Gharbi IV). Surgery is the treatment of choice for Gharbi III cysts due to the high recurrence rates reported in percutaneous treatment studies (28, 29). Proposed explanations for these findings include multiple daughter cysts within a solid matrix being more difficult to access and drain, as well as the presence of undetected very small daughter cysts that could not have enough exposure to the scolicidal agent or were not properly drained (29, 30). Moreover, two patients in our study had inactive cysts excised and one patient was referred to Cusco Regional Hospital for management of a Gharbi IV cyst. Ultrasound screening for early diagnosis along with standardization of WHO-IWGE staging and implementation of percutaneous invasive procedures may improve CE outcomes in Sicuani, decreasing costs, unnecessary procedures and hospitalization time.
We found a higher post-surgical recurrence rate in comparison with other studies evaluating this measure (8, 10, 11, 31). This is particularly concerning, when only a minority of patients had documentation of the recommended surgical spillage prevention measures. In some cases, it was described that surgical field drapes were soaked on normal saline or iodine rather than hypertonic saline and the instillation of a scolicidal agent into the cyst cavity was performed after the cyst opening and evacuation of contents. Although we did not find a protective association between these measures and recurrence, proper standardization has been associated with null recurrence at 24 months in prospective studies (16). Furthermore, pre-surgical ABZ had a paradoxically positive association with recurrence in our cohort. This phenomenon was observed in other study in which patients receiving antiparasitics were associated with higher risk of recurrence (9). This could be the result of an indication bias in a retrospective study, in which the more complicated patients were treated more carefully and documentation was more precise. Pre-surgical ABZ remains a core measure of protoscolex spillage-prevention in liver CE (28). Prospective studies carefully assessing the appropriate timing and dosing of antiparasitics will help elucidate this clinical gap to improve outcomes.
Our study had limitations that should be acknowledged. First, this is a retrospective review of paper-form medical charts with a small sample size. Missing information in certain variables such as ultrasound staging did not allow testing their association with our outcome. Second, as the Hospital Archives Department had a digitalized database of medical record numbers since 2017, cases of years 2010-2016 had to be handsearched in the surgical logbooks. Therefore, patients who were hospitalized during this period and did not have surgery are missing in our cohort. Third, the description of symptoms, complications, and management of patients in our study represent the judgement of practicing clinicians in Sicuani during a large time span. These may not concur with the standard of care in other contexts and generalizations should be carefully assessed. Finally, the lack of follow up in some patients may have underestimated our recurrence outcome.
In conclusion, advanced and complicated liver CE and post-surgical recurrence were common among hospitalized patients in Sicuani, Cusco, Peru. Practical measures including standardization of ultrasound staging-guided clinical management, protoscolex spillage-prevention measures, and follow-up could effectively decrease the burden linked to clinical care, improving outcomes and decreasing costs in Sicuani.
Financial support
This study was supported by the “Bologna Master Thesis” funding from the Deparment of Education of the University of Basel, Switzerland.
Conflicts of interest
The authors have no competing interests.
Authors’ details
RP-R: Swiss Tropical and Public Health Institute, associated to University of Basel, Allschwil, Switzerland, Kreuzstrasse 2, 4123 Allschwil, Switzerland, repineda1{at}gmail.com; MMC: Cusco Branch – Alexander von Humboldt Tropical Medicine Institute, Universidad Peruana Cayetano Heredia and Infectious Disease Division, University of Texas Medical Branch, Galveston Texas, 301 University Boulevard, Rte. 0435, Galveston, TX 77555-0435, USA, micabada{at}utmb.edu; BB: School of Global Health, Chinese Centre for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China and National Center for Zoonotic Disease, Ulaanbaatar 18131, Mongolia, bolor.bold.ch{at}gmail.com; MLM: Cusco Branch – Alexander von Humboldt Tropical Medicine Institute, Universidad Peruana Cayetano Heredia, Jr. Jose Carlos Mariategui J6 Urb. Santa Monica, Distrito Wanchaq 08002, Cusco, Peru, maria.morales.f{at}upch.pe; JH: Swiss Tropical and Public Health Institute, associated to University of Basel, Allschwil, Switzerland, Kreuzstrasse 2, 4123 Allschwil, Switzerland, jan.hattendorf{at}swisstph.ch; PV: Departamento de Cirugia, Hospital Alfredo Callo Rodriguez – Sicuani, Av. Manuel Callo Zevallos Nro. 519, Sicuani, Cusco, Peru, miqxonc21{at}gmail.com; RB: Programa de Control de Enfermedades Zoonoticas, Gerencia Regional de Salud de Cusco, Prolongacion de la Cultura 1525, Cusco 08003, Peru, bascopecusco{at}gmail.com; JZ: Swiss Tropical and Public Health Institute, associated to University of Basel, Allschwil, Switzerland, Kreuzstrasse 2, 4123 Allschwil, Switzerland, jakob.zinsstag{at}swisstph.ch.
Acknowledgements
We thank the Alfredo Callo Rodriguez Hospital’s Administration Office as well as the personnel of the Statistics and Archives Department for their assistance during the study period.
References
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos